Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05883436 · ClinicalTrials.gov registry record · NA

Investigation of DEXA-C Anterior Cervical Interbody System

A NA study of Degenerative Disc Disease, sponsored by Aurora Spine and Pain.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
4
Study locations

NCT05883436 is a NA study of Degenerative Disc Disease that is actively recruiting participants, run by Aurora Spine and Pain. The registered enrollment target is 80 participants, below the 167-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (52% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05883436, a NA study of Degenerative Disc Disease, is actively recruiting participants, sponsored by Aurora Spine and Pain.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
4
Study locations

Study Summary

FDA Cleared interbody product for the cervical spine, designed to match a patients DEXA scan for increase in fusion rate.

Conditions Studied

Interventions

  • DEVICE DEXA-C Cervical Interbody System

Study Locations (4)

California

  • UCI Center for Clinical Research - Orange

Kentucky

  • Orthopaedic Institute of Western KY - Paducah

Louisiana

  • Koga Neurosurgery - Covington

Oklahoma

  • Optima Orthopedics - Oklahoma City

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2023-02-22
Est. Completion 2027-02-22
Phase NA

Sponsor

Aurora Spine and Pain

1 total trials

What the Registry Record Tells You About NCT05883436

The ClinicalTrials.gov registry entry for NCT05883436 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 167-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (52% lower). The listed sponsor is Aurora Spine and Pain, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Degenerative Disc Disease appearing as the primary indexed condition, and to 1 intervention - of which DEXA-C Cervical Interbody System is the first listed.

NCT05883436 reports 4 study locations spanning 4 distinct geographic areas - top geographies include California, Kentucky, Louisiana.

Frequently Asked Questions

What is clinical trial NCT05883436 about?

NCT05883436 is a clinical study titled "Investigation of DEXA-C Anterior Cervical Interbody System". FDA Cleared interbody product for the cervical spine, designed to match a patients DEXA scan for increase in fusion rate.

What is the current status of trial NCT05883436?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2023-02-22. Estimated completion is 2027-02-22.

What conditions does trial NCT05883436 study?

This clinical trial studies the following conditions: Degenerative Disc Disease.

What interventions are being tested in trial NCT05883436?

The interventions under investigation include: DEXA-C Cervical Interbody System (DEVICE).

Who is sponsoring clinical trial NCT05883436?

This trial is sponsored by Aurora Spine and Pain, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05883436 being conducted?

This trial has 4 study locations across California, Kentucky, Louisiana, Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Degenerative Disc Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.